基本信息
文件名称:TGX-221-Standard-生命科学试剂-MCE.pdf
文件大小:465.05 KB
总页数:1 页
更新时间:2025-05-23
总字数:约2.73千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

TGX-221(Standard)

Cat.No.:HY-10114R

CASNo.:663619-89-4

分?式:C??H??N?O?

分?量:364.44

作?靶点:PI3K

作?通路:PI3K/Akt/mTOR

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性TGX-221(Standard)是TGX-221的分析标准品。本产品?于研究及分析应?。TGX-221是?种?效的、选择性

的、细胞膜渗透的PI3Kp110β抑制剂,常?于癌症研究。

IC50TargetIC50:8.5nM(p110β),211nM(p110δ)[5]

REFERENCES

[1].ZhaoY,etal.ProdrugstrategyforPSMA-targeteddeliveryofTGX-221toprostatecancercells.MolPharm.2012Jun4;9(6):1705-16.

[2].GeQ,etal.Thephosphoinositide3-kinasep110δmodulatescontractileproteinproductionandIL-6releaseinhumanairwaysmooth

muscle.JCellPhysiol.2012Aug;227(8):3044-52.

[3].MüllerKM,etal.RoleofproteinkinaseCandepidermalgrowthfactorreceptorsignallingingrowthstimulationbyneurotensinincolon

carcinomacells.BMCCancer.2011Oct2;11:421.

[4].SturgeonSA,etal.Advantagesofaselectivebeta-isoformphosphoinositide3-kinaseantagonist,ananti-thromboticagentdevoidof

othercardiov